Wang SC - Search Results

1

Enhanced resistance to tamoxifen by the c-ABL proto-oncogene in breast cancer.

Zhao H, Ou-Yang F, Chen IF, Hou MF, Yuan SS, Chang HL, Lee YC, Plattner R, Waltz SE, Ho SM, Sims J, Wang SC. Zhao H, et al. Among authors: wang sc. Neoplasia. 2010 Mar;12(3):214-23. doi: 10.1593/neo.91576. Neoplasia. 2010. PMID: 20234815 Free PMC article.

2

Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2.

Wang SC, Lien HC, Xia W, Chen IF, Lo HW, Wang Z, Ali-Seyed M, Lee DF, Bartholomeusz G, Ou-Yang F, Giri DK, Hung MC. Wang SC, et al. Among authors: wang z. Cancer Cell. 2004 Sep;6(3):251-61. doi: 10.1016/j.ccr.2004.07.012. Cancer Cell. 2004. PMID: 15380516 Free article.

3

AIM2 suppresses human breast cancer cell proliferation in vitro and mammary tumor growth in a mouse model.

Chen IF, Ou-Yang F, Hung JY, Liu JC, Wang H, Wang SC, Hou MF, Hortobagyi GN, Hung MC. Chen IF, et al. Among authors: wang h, wang sc. Mol Cancer Ther. 2006 Jan;5(1):1-7. doi: 10.1158/1535-7163.MCT-05-0310. Mol Cancer Ther. 2006. PMID: 16432157

4

Targeting tyrosine phosphorylation of PCNA inhibits prostate cancer growth.

Zhao H, Lo YH, Ma L, Waltz SE, Gray JK, Hung MC, Wang SC. Zhao H, et al. Among authors: wang sc. Mol Cancer Ther. 2011 Jan;10(1):29-36. doi: 10.1158/1535-7163.MCT-10-0778. Mol Cancer Ther. 2011. PMID: 21220489 Free PMC article.

5

Overcoming resistance to fulvestrant (ICI182,780) by downregulating the c-ABL proto-oncogene in breast cancer.

Zhao H, Lo YH, Yu L, Wang SC. Zhao H, et al. Among authors: wang sc. Mol Carcinog. 2011 May;50(5):383-9. doi: 10.1002/mc.20721. Epub 2010 Dec 28. Mol Carcinog. 2011. PMID: 21480391

6

Inhibition of c-ABL sensitizes breast cancer cells to the dual ErbB receptor tyrosine kinase inhibitor lapatinib (GW572016).

Lo YH, Ho PC, Zhao H, Wang SC. Lo YH, et al. Among authors: wang sc. Anticancer Res. 2011 Mar;31(3):789-95. Anticancer Res. 2011. PMID: 21498698

7

Interaction of proliferation cell nuclear antigen (PCNA) with c-Abl in cell proliferation and response to DNA damages in breast cancer.

Zhao H, Ho PC, Lo YH, Espejo A, Bedford MT, Hung MC, Wang SC. Zhao H, et al. Among authors: wang sc. PLoS One. 2012;7(1):e29416. doi: 10.1371/journal.pone.0029416. Epub 2012 Jan 4. PLoS One. 2012. PMID: 22238610 Free PMC article.

8

Cross-talk between HER2 and MED1 regulates tamoxifen resistance of human breast cancer cells.

Cui J, Germer K, Wu T, Wang J, Luo J, Wang SC, Wang Q, Zhang X. Cui J, et al. Among authors: wang sc, wang j, wang q. Cancer Res. 2012 Nov 1;72(21):5625-34. doi: 10.1158/0008-5472.CAN-12-1305. Epub 2012 Sep 10. Cancer Res. 2012. PMID: 22964581 Free PMC article.

9

miR-125a-5p is a prognostic biomarker that targets HDAC4 to suppress breast tumorigenesis.

Hsieh TH, Hsu CY, Tsai CF, Long CY, Chai CY, Hou MF, Lee JN, Wu DC, Wang SC, Tsai EM. Hsieh TH, et al. Among authors: wang sc. Oncotarget. 2015 Jan 1;6(1):494-509. doi: 10.18632/oncotarget.2674. Oncotarget. 2015. PMID: 25504437 Free PMC article.

10

Combined inhibition of EGFR and c-ABL suppresses the growth of triple-negative breast cancer growth through inhibition of HOTAIR.

Wang YL, Overstreet AM, Chen MS, Wang J, Zhao HJ, Ho PC, Smith M, Wang SC. Wang YL, et al. Among authors: wang sc, wang j. Oncotarget. 2015 May 10;6(13):11150-61. doi: 10.18632/oncotarget.3441. Oncotarget. 2015. PMID: 25883211 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,275 results

Search Page

Filters